Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Graph

IMDX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2021-02-23: Research and development $125.00K; Net income -$125.00K.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IMDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Kitted Products$21.00KLaboratory Services$218.00KRevenue$239.00KCost of revenue$82.00KGross profit$157.00KOperating expenses$11.56MOperating income-$11.40MOther income, net$162.00KResearch & development$4.49MIncome tax$0.00Net income-$11.26M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IMDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Asia Pacific$6.00KEurope$15.00KUS$218.00KRevenue$239.00KCost of revenue$82.00KGross profit$157.00KOperating expenses$11.56MOperating income-$11.40MOther income, net$162.00KResearch & development$4.49MIncome tax$0.00Net income-$11.26M

Income Statement Location

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IMDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Kitted Products$21.00KLaboratory Services$218.00KRevenue$239.00KCost of revenue$82.00KGross profit$157.00KOperating expenses$11.56MOperating income-$11.40MOther income, net$162.00KResearch & development$4.49MIncome tax$0.00Net income-$11.26M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 2 month

Period endResearch and developmentNet income
2021-02-23$125.00K-$125.00K

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$239.00K$82.00K$4.49M$11.56M$0.00-$11.26M
2026-03-31$32.00K$17.00K$4.95M$4.43M$0.00-$4.29M
2025-12-31$1.14M*$643.00K*$5.83M*$23.93M*$0.00*$27.22M*
2025-09-30$260.00K$121.00K$3.88M$11.19M$0.00-$10.85M
2025-06-30$518.00K$180.00K$3.27M$10.18M$0.00-$9.74M
2025-03-31$2.14M$813.00K$2.92M$8.12M$0.00-$6.67M
2024-09-30$115.00K$43.00K$2.82M$13.56M$0.00-$13.49M
2024-06-30$104.00K$32.00K$2.45M$4.68M$0.00-$4.53M
2024-03-31$176.00K$109.00K$2.31M$9.31M$0.00-$9.13M
2023-09-30$429.00K$159.00K$2.19M$6.76M(m)-$6.49M
2023-06-30$463.00K$169.00K$2.44M$8.57M(m)-$8.33M
2023-03-31$297.00K$265.00K$2.13M-$5.84M(m)$3.03M
2022-09-30$67.00K$314.00K$1.47M$1.44M(m)-$9.33M
2022-06-30$237.00K$183.00K$2.44M$1.66M(m)-$8.30M
2022-03-31$380.00K$105.00K$2.01M$3.26M(m)-$10.29M
2021-12-31$3.59M$2.22M$4.59M(m)-$97.00K-$35.88M
2021-09-30$984.00K$860.00K$3.14M$12.74M(m)-$13.80M
2021-06-30$2.03M$1.35M$2.54M$13.17M-$1.79M-$10.49M
2021-03-31$1.12M$738.00K$3.36M$11.44M-$7.56M-$3.92M
2020-12-31$503.00K$716.00K$1.80M(m)$159.00K-$6.31M
2020-09-30$555.00K$601.00K$2.62M$6.20M(m)-$6.78M
2020-06-30$143.00K$365.00K$3.23M$8.55M(m)-$9.11M
2020-03-31$16.00K$173.00K$2.16M$8.45M$1.09M-$7.73M
2019-09-30(m)(m)$1.63M$5.26M(m)-$5.22M
2019-06-30(m)(m)$1.51M$5.46M(m)-$5.38M
2019-03-31(m)(m)$1.34M$4.00M(m)-$3.86M
2018-09-30(m)(m)$1.53M$3.02M(m)-$2.97M
2018-06-30(m)(m)$2.32M$4.23M(m)-$4.50M
2018-03-31(m)(m)$1.46M$3.91M(m)-$3.78M
2017-09-30(m)(m)$1.84M$6.83M(m)-$6.91M
2017-06-30(m)(m)$2.00M$3.59M(m)-$3.80M
2017-03-31(m)(m)$1.83M$4.53M(m)-$4.70M
2016-09-30(m)(m)$1.36M$2.58M(m)-$2.60M
2016-06-30(m)(m)$1.20M$2.53M(m)-$2.54M
2016-03-31$0.00(m)$1.69M$2.93M(m)-$2.93M
2015-09-30(m)(m)$1.09M$2.41M(m)-$2.42M
2015-06-30(m)(m)$886.00K$1.41M(m)-$1.41M
2015-03-31(m)(m)$1.12M$1.37M(m)-$1.37M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$271.00K$99.00K$9.44M$15.99M$0.00-$15.55M
2025-06-30$2.66M$993.00K$6.19M$18.30M$0.00-$16.41M
2024-06-30$280.00K$141.00K$4.76M$13.99M$0.00-$13.66M
2023-06-30$760.00K$434.00K$4.56M$2.73M(m)-$5.30M
2022-06-30$617.00K$288.00K$4.45M$4.92M(m)-$18.59M
2021-06-30$3.15M$2.09M$5.90M$24.61M-$9.36M-$14.41M
2020-06-30$158.00K$538.00K$5.38M$16.82M-$1.09M-$16.84M
2019-06-30(m)(m)$2.85M$9.46M(m)-$9.25M
2018-06-30(m)(m)$3.78M$8.13M(m)-$8.28M
2017-06-30(m)(m)$3.83M$8.12M(m)-$8.51M
2016-06-30$0.00(m)$2.88M$5.46M(m)-$5.47M
2015-06-30(m)(m)$2.00M$2.77M(m)-$2.78M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$2.92M$1.11M$10.07M$29.49M$0.00-$27.27M
2024-09-30$395.00K$184.00K$7.58M$27.56M$0.00-$27.15M
2023-09-30$1.19M$593.00K$6.75M$9.49M(m)-$11.79M
2022-09-30$684.00K$602.00K$5.92M$6.36M(m)-$27.92M
2021-09-30$4.14M$2.95M$9.04M$37.35M-$9.36M-$28.21M
2020-09-30$713.00K$1.14M$8.00M$23.02M-$1.09M-$23.62M
2019-09-30(m)(m)$4.48M$14.72M(m)-$14.47M
2018-09-30(m)(m)$5.31M$11.15M(m)-$11.26M
2017-09-30(m)(m)$5.67M$14.96M(m)-$15.41M
2016-09-30$0.00(m)$4.25M$8.05M(m)-$8.06M
2015-09-30(m)(m)$3.10M$5.18M(m)-$5.20M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$4.05M$1.75M$15.90M$53.42M$0.00-$50.22K
2024-12-31$1.88M$1.05M$9.84M$61.78M$0.00-$60.66K
2023-12-31$1.50M$1.00M$9.29M$25.55M$0.00-$27.78K
2022-12-31$958.00K$880.00K$7.30M$17.98M(m)-$72.90M
2021-12-31$2.20M$697.00K$5.04M$55.15M-$9.26M-$64.10M
2020-12-31$1.22M$1.85M$9.80M$29.07M-$1.25M-$29.93M
2019-12-31(m)(m)$6.79M$22.24M(m)-$22.43M
2018-12-31(m)(m)$6.51M$15.20M(m)-$15.75M
2017-12-31(m)(m)$7.17M$18.85M(m)-$19.38M
2016-12-31(m)(m)$5.68M$11.14M(m)-$11.17M
2015-12-31$0.00(m)$4.53M$8.72M(m)-$8.73M
2014-12-31(m)(m)$3.96M$4.97M(m)-$4.99M

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92